Join to View Full Profile
Crb I RM 1461650 Orleans StBaltimore, MD 21287
Phone+1 410-502-8164
Fax+1 410-614-4073
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Josh Lauring, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is an Assistant Professor of Oncology at Johns Hopkins University School of Medicine.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2003 - 2006- Johns Hopkins UniversityResidency, Internal Medicine, 2000 - 2003
- Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
MD State Medical License 2003 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
Publications & Presentations
PubMed
- 9 citationsSafety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.Ravit Geva, Maria Vieito, Jorge Ramon, Ruth Perets, Manuel Pedregal
Cancer Immunology, Immunotherapy. 2024-08-06 - 29 citationsActive growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibition.Gemma A Wilson, Karla Vuina, Georgina Sava, Caroline Huard, Leticia Meneguello
Molecular Cell. 2023-11-16 - 15 citationsPhase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes.Tamanna Haque, Felix López Cadenas, Blanca Xicoy, Ana Alfonso-Pierola, Uwe Platzbecker
Leukemia Research. 2023-11-01
Press Mentions
Hopkins Researcher Describes Evolving Challenges of Targeting PI3K in Breast CancerMarch 12th, 2015
